CAR T cell treatment was also accompanied with the strongest interferon (IFN)γ release within the tumor two days after treatment whereas IFNγ concentrations within the plasma remained below detection limit (Figures 4F and S6A). This evidence concerns the gene IFNG and neoplasm.